Are there any food restrictions while taking GLP-1 receptor agonists
The glucagon receptor component is expected to provide unique metabolic effects including increased energy expenditure and enhanced hepatic lipid oxidation, which may contribute to the substantial body weight reductions observed in Phase 2 clinical trials
If hunger has returned, the patient may need satiety-focused nutrition, meal timing, fiber, and a realistic plan for cravings
Our comprehensive Pendulum GLP-1 Probiotic Pro review covers the product from every angle, including efficacy, value, and alternatives
Retatrutide (Retara), a triple GIP/GLP-1/glucagon agonist, produced the highest mean weight loss in clinical trials (24.2% at 48 weeks)
90 mg: -2.50, p=0.0008)